Patent · US Active

High level expression of recombinant toxin proteins

US8530171B2 · kind B2 · utility

11Cited by
32References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2011
Grant dateSep 10, 2013
Priority date
Expiry dateJun 2, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24068
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to the field of recombinant toxin protein production in bacterial hosts. In particular, the present invention relates to production processes for obtaining high levels of a recombinant CRM197, Diphtheria Toxin, Pertussis Toxin, Tetanus Toxoid Fragment C, Cholera Toxin B, Cholera holotoxin, and Pseudomonas Exotoxin A, from a bacterial host.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.